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IRF-7 plays an essential role in virus-activated transcription of IFNA genes. To analyze functional domains of IRF-7 we have
constructed an amino-terminal deletion mutant of IRF-7 (237–514) which exerted a dominant negative (DN) effect on
virus-induced expression of the endogenous Type I IFN genes. Focusing on the molecular mechanism underlying the
dominant negative effect of IRF-7 DN, we found that virus-activated transcription of endogenous IFNA genes requires
full-length IRF-7 and that Serine 483 and 484 play an essential role. While IRF-7 DN had no effect on virus-stimulated nuclear
translocation of IRF-3 and IRF-7, the binding of IRF-7 DN to IRF-3 and IRF-7 was detected by GST pull-down assay as well as
by immunoprecipitation in infected cells, indicating that IRF-7 DN targets both IRF-7 and IRF-3. The region by which IRF-7
interacts with IRF-3 was mapped between amino acid 418 and 473. Overexpression of IRF-7 DN in virus-infected 2FTGH cells
resulted in an inhibition of IFN synthesis and in a significant reduction of binding of both IRF-3 and IRF-7 to the IFNA1
promoter. Interestingly, the IRF-7 DN-mediated suppression of IFNA gene expression can be negated by overexpression of
IRF-3. Altogether these results suggest that the IRF-3/IRF-7 complexes are biologically active and are involved in virus-
activated transcription of endogenous IFNA genes. © 2001 Academic PressKey Words: interferon; interferon regulatory factor-7; interferon regulatory factor-3; dominant negative; transcription; New
Castle Disease Virus; Sendai Virus.
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aINTRODUCTION
Type I IFNs (IFNA and IFNB) exert multiple biological
activities upon binding to their cognate cellular recep-
tors. The Type I IFN-activated Jak-STAT signaling path-
way leads to the expression of a set of immediate-early
response genes (IFN stimulated genes, ISGs), which
play important roles in innate and adaptive immune re-
sponse against viral and bacterial infection (Darnell,
1997; Stark et al., 1998). The inducible expression of Type
I IFN gene (IFNA and IFNB) is tightly regulated at the
transcriptional level (Bisat et al., 1988). While the synthe-
sis of IFNA is mainly restricted to the cells of lymphoid
origin, the synthesis of the IFNB can be induced in most
of the cell types. Recently, a CD41 CD11c2 type 2
endritic cell precursor has been identified as the high
FNA producing cell that, upon viral infection, produces
00-1000 fold more Type I IFN than do the other lymphoid
ell types (Siegal et al., 1999).
Extensive studies focusing on the regulation of virus-
nduced transcription of a single-copy IFNB gene have
evealed that it requires the assembly of a multicompo-
ent complex, named enhanceosome, on the promoter.
1 These authors contributed equally to this work.
2 To whom reprint request should be addressed at The Johns Hop-kins University, Oncology Center, Rm. 351, 1650 Orleans Street, Balti-
more, MD 21231. Fax: (410) 955-0840. E-mail: parowe@jhmi.edu.
273his enhanceosome consists of NFkB, IRFs, ATF2, c Jun,
MGI (Y), and transcription coactivator, p300/CBP (Kim
nd Maniatis, 1997; Merika et al., 1998; Wathelet et al.,
1998). The p300/CBP has been shown to acetylate the
local histone H3 and H4 and possibly make the chroma-
tin structure more accessible to the transcription ma-
chinery (Agalioti et al., 2000; Parekh and Maniatis, 1999).
In contrast, the factors involved in the regulation of IFNA
genes are much less defined. Although the promoter
region containing the virus-responsive element (VRE) of
all IFNA genes show only small variations, the expres-
sion of individual IFNA subtype varies in a cell type
specific manner (Bisat et al., 1988).
The promoters of IFNA, IFNB, and ISG genes all contain
multiple GAAANN repeats that constitute the binding sites
(IRF-E, PRD-I/III, and ISRE, respectively) for proteins of the
IRF family (Nguyen et al., 1997). The IRF family members
share high homology in their N-terminal DNA-binding do-
main (DBD) which contains five conserved tryptophan re-
peats and is related to Myb (Veals et al., 1992), while the
C-terminal regions are more diverse and are related to the
proteins of the Smad family (Eroshkin and Mushegian,
1999). All the cellular IRFs bind to similar DNA sequence.
The structural analysis of IRF-2 bound to the DNA has
shown that the recognition sequence is AANNGAAA
(where N can be any base; Fujii et al., 1999).
Recent studies indicated that the activation of IRF-3
0042-6822/01 $35.00
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274 AU, YEOW, AND PITHAand IRF-7 are important for the expression of Type I IFN
genes (Au et al., 1995; Lin et al., 1998; Navarro et al.,
998; Weaver et al., 1998; Yoneyama et al., 1998). It was
hown that in infected cells, IRF-3 is phosphorylated on
he serine residues close to the C terminus of IRF-3 and
ccumulates in the nucleus, where it interacts with CBP/
300 (Kumar et al., 2000; Lin et al., 1998; Weaver et al.,
998; Yoneyama et al., 1998). IRF-7 was also shown to
articipate in the regulation of Type I IFN gene expres-
ion in infected cells. (Au et al., 1998; Sato et al., 1998)
and four splice variants of human IRF-7 (IRF-7A, B, C, and
H) have been identified (Au et al., 1998; Zhang and
Pagano, 1997). Although IRF-7A, B, and C were initially
demonstrated as negative regulators of the Qp region
that regulates expression of ENBA-1 gene in Type III
latency of EB virus infection (Zhang and Pagano, 1997).
We, as well as others, have shown that overexpression of
IRF-7H or IRF-7A result in an activation of promoters of
Type I IFN genes (Au et al., 1998; Wathelet et al., 1998).
Unlike IRF-3, which is constitutively expressed, the ex-
pression of IRF-7 is inducible by Type I IFN, and by the
EB virus-encoded latent membrane protein 1 (LMP-1) (Au
et al., 1998; Marie et al., 1998; Sato et al., 1998; Zhang and
agano, 2000). The importance of murine IRF-7 in the
ype I IFN gene expression was first demonstrated by
aniguchi’s group, who showed that virus-activated tran-
cription of Type I IFN genes depends on synthesis of
RF-7 involved in the positive feedback regulation of Type
IFN genes (Sato et al., 1998). Levy’s group has then
hown that virus infection leads to transcriptional activa-
ion of the IFNB and IFNA4 genes, while the expression
f the other IFNA genes requires interferon-mediated
nduction of IRF-7 (Marie et al., 1998). We have shown
ecently that induction of all the human IFNA subtypes by
iral infection requires IRF-7, such that in cell line 2FTGH
hat is incapable of expressing IRF-7 gene (Au et al.,
998; Lu et al., 2000), ectopic expression of IRF-7H (here-
fter referred as IRF-7) restores virus-induced expres-
ion of IFNA genes (Yeow et al., 2000). These results
suggest that tissue-specific expression of IFNA genes is
in part regulated by the presence of IRF-7.
In this study, we have used a dominant negative mutant
of IRF-7 to dissect the molecular interactions that are es-
sential for the virus-activated expression of endogenous
IFNA genes. Our results revealed the functional importance
of the interaction between IRF-3 and IRF-7 in IFNA gene
expression; furthermore we have mapped the association
domains through which IRF-3 and IRF-7 interact.
RESULTS
The carboxyl-terminal part of IRF-7 (237–514)
suppresses virus-mediated activation of murine IFNA
and IFNB genesWe have shown previously that the amino-terminal
portion of IRF 7 (1–237) contains a DNA binding domainand a transactivation domain, whereas the carboxyl ter-
minus of IRF-7 (428–514) designated as a regulatory
domain (RD) is inhibitory to the virus-activated expres-
sion of murine IFNA4 reporter gene (Au et al., 1998).
Similarly, an auto inhibitory domain has also been lo-
cated at the C-terminal part of IRF-3 (380–427; Lin et al.,
1999). It was demonstrated that IRF-4 and IRF-8 (ICSBP)
contained an IRF association domain (IAD) which medi-
ated their interaction with IRF-1, IRF-2, and proteins of ets
family, such as PU.1 (Meraro et al., 1999; Nguyen et al.,
1997). Protein sequence analysis indicates that IRF-3
and IRF-7 also contain regions that show significant
homology to the IAD (Meraro et al., 1999; also see Fig.
5B). To better understand the molecular interactions that
may be critical for the ability of IRF-7 to bind DNA as well
as to modulate transcription of IFNA genes, we gener-
ated a flag-tagged IRF-7 deletion mutant consisting of
a.a. 237–514 of IRF-7. This IRF-7 mutant, which contains
neither the DBD nor the transactivation domain, was
tested for its ability to modulate transcription of murine
Type I IFN genes in L929 cell line that constitutively
expresses IRF-7 dominant negative(DN) (237–514). The
virus-induced expression of endogenous IFNA and IFNB
genes was determined by semiquantitative RT-PCR. No
expression of IFNA and IFNB messages was detected in
infected IRF-7 DN (237–514) expressing cells, while in
infected parental cells, both IFNA and IFNB in RNA were
detected (Fig. 1). The b actin and IRF-7 DN (237–514)
messages were detected in all samples. These cells
also expressed both IRF-3 and IRF-7 (data not shown). It
was shown previously that IRF-3 alone can activate ex-
pression of murine and human IFNB genes (Marie et al.,
1998; Yeow et al., 2000). The absence of both IFNA and
IFNB mRNAs in infected, IRF-7 DN (237–514) expressing
L-929 cells indicates that IRF-7 DN (237–514) may target
both IRF-7 and IRF-3.
Virus infection leads to a phosphorylation of IRF-3 at
the C-terminal serine-rich region (Lin et al., 1998; Weaver
t al., 1998) and phosphorylation of S385 and S386 is
equired for the translocation of IRF-3 into the nucleus
nd its interaction with p300/CBP (Yoneyama et al., 1998).
Furthermore, phosphorylation at the downstreamed
serine and threonine residues was shown to induce a
conformational change, releasing the autoinhibitory (AI)
domain and facilitating the DNA-binding of IRF-3 (Lin et
al., 1999). Although the S425 and S426 residues of mu-
rine IRF-7 were also found to be important to its tran-
scriptional activity and homodimer formation (Marie et al.,
1998, 2000), the biological role of these two serine residues
in human IRF-7 have never been determined. Since IRF-7
DN (237–514) contains the consensus serine-rich se-
quence, we sought to determine whether IRF-7 DN (237–
514) is phosphorylated in infected cells and whether the
S483 and S484 of human IRF-7 are targeted for phosphor-
ylation. To this effect, we created IRF-7 DN (237–514) phos-
phorylation mutant (IRF-7 DN ph-) in which serine residues
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275FUNCTIONAL ASSOCIATION BETWEEN IRF -3 AND IRF -7at the position 483 and 484 were replaced by phenylalanine
and alanine, respectively. The plasmid encoding IRF-7 DN
(237–514) or IRF-7 DN ph- was transfected to 293 cells and
16 h posttransfection; cells were labeled with 32P-or-
hophosphate and infected with Sendai virus for 4 h. As
hown in Fig. 2, Sendai virus infection of IRF-7 DN (237–514)
ransfected 293 cells resulted in the phosphorylation of
FIG. 1. Effects of N-terminal deletion mutant (237–514) of IRF -7 on
virus-stimulated expression of endogenous IFNA and IFNB genes.
Induction of IFNA and IFNB transcripts was determined in IRF -7 DN
(237–514) stable transfected L929 cells. One mg of RNA form L929 cells
r L929 cells expressing IRF -7 DN (237–514) (uninfected or infected
ith NDV for 6 h.) was reverse-transcribed as described under Mate-
ials and Methods. Constant volume of each RT reaction was then
aken for the PCR amplification with primer sets specific b-actin, IFNA,
IFNB, and IRF -7.
FIG. 2. S483 and S484 are essential for virus-induced phosphoryla-
tion of IRF -7 DN (237–524) in 293 cells. Human 293 cells were trans-
fected with plasmids encoding Flag-tagged IRF -7 DN (237–514), IRF -7
DN ph-, or with pcDNA empty vector. Sixteen hours after transfection,
cells were first cultured in phosphate-free medium for 2 h and then
infected with Sendai virus and labeled with 32P-orthophosphate for 4 h.
mmunoprecipitation with anti-Flag antibody was done with the same
mount of lysate and precipitated proteins were resolved by SDS–
AGE. Relative levels of Flag-tagged IRF -7 DN (237–514) and IRF -7 DNv
o
h- were determined by Western blot. The amino acid sequence and
he point mutations are shown.RF-7 DN (237–514), while no phosphorylation of IRF-7 DN
h- was detected. It is noteworthy that the IRF-7 DN (237–
14) was also phosphorylated at low levels in uninfected
ells, which indicates that a constitutive kinase activity is
resent in uninfected cells. The relative levels of IRF-7 DN
rotein were determined by the Western blot in which IRF-7
N (237–514) and IRF-7 DN ph- mutants were expressed in
ransfected cells at about the same level.
RF-7 DN (237–514) does not inhibit the virus-induced
uclear translocation of IRF-3 and IRF-7
It was suggested that IRF-3 and IRF-7 may be targeted
y a similar kinase (Marie et al., 1998). To further dissect
he mechanism by which IRF-7 DN (237–514) suppressed
he virus-induced IFNA gene expression, we tested
hether IRF-7 DN (237–514) could compete with IRF-3
nd IRF-7 for the virus-activated kinase and conse-
uently prevent the nuclear localization of IRF-7 and
RF-3 in virus-infected cells. As shown in Fig. 3, IRF-7/
FP and IRF-3/GFP are mainly localized in the cytoplasm
f uninfected 2FTGH cells, and upon Sendai virus infec-
ion, both IRF-7/GFP and IRF-3/GFP are concentrated in
he nucleus. The virus-induced nuclear translocation of
RF-7/GFP and IRF-3/GFP was not affected by the pres-
nce of IRF-7 DN (237–514). Therefore, the inhibition
onferred by IRF-7 DN (237–514) is not due to the inhi-
ition of the nuclear translocation of IRF-3 or IRF-7. It is
oticeable that the distribution of IRF-7/GFP in Sendai
FIG. 3. IRF -7 DN (237–514) does not prevent the virus-induced
nuclear translocation of IRF -7 and IRF -3. IRF -7/GFP or IRF -3/GFP
expression plasmid (Lin et al., 1998) was cotransfected with an empty
ector, IRF -7 DN (237–514) or IRF -7 and IRF -7 DN (237–514) expression
lasmids. Sixteen hours after transfection, the transfected 2FTGH cells
ere infected with Sendai virus for 6 h. The image of one or two
epresentative cells are shown at the same magnification.irus infected 2FTGH cells is more distinct than that
bserved previously in NDV-infected L-929 cells (Au et
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276 AU, YEOW, AND PITHAal., 1998); this difference could be due to the different cell
types and viruses used in the experiments.
Activation of endogenous IFNA genes in virus-
infected human 2FTGH cells requires the presence of
full-length IRF-7 and its phosphorylation
We have previously shown that IRF-7 has a critical role
in activation of IFNA genes in human 2FTGH cells (Yeow
et al., 2000). Using these cells, we analyzed the func-
tional domain of IRF-7 required for the transcriptional
activation of the endogenous IFNA genes. The IRF-7
deletion mutants were therefore expressed in 2FTGH
cells and the virus-mediated expression of IFNA and
IFNB genes was determined by RT-PCR. To confirm that
RT-PCR is in a linear response range, serial dilution of
the RNA from infected, IRF-7 transfected 2FTGH cells
was subjected to the RT-PCR. As demonstrated in Fig.
4A, the level of the amplified IFNA RT-PCR product was
within the linear range of amplification. Since all the
amplifications in the following experiments (Figs. 4 and
7) were done under identical conditions, these results
FIG. 4. Activation of expression of endogenous IFNA genes by virus re
arious amounts of total RNA collected from Sendai virus-infected, IRF
was used for RT-PCR (30 cycles) to amplify IFNA messages. cDNA deri
5), or 35 cycles (lane 6) of amplification. One microgram of RNA and 30
and 6. (B) 2FTGH cells were transfected with the indicated plasmids and
of respective transcripts were determined by RT-PCR. The primer set
RF -3/p65. The primer set used to amplify IFNA and IFNB were describ
RF -7 transcripts, in which a primer set (59 primer ATGCCAGTCCCCGA
f IRF -7 was used to detect the transcripts of IRF -7 (1–237) and IRF -7
rimer set specific for the 39 end of IRF -7 was used as described und
or 2 is given based on the presence or absence of amplified DNA fraindicate that our assays were semiquantitative. As
shown in Fig. 4B and summarized in Fig. 4C, the intensityof the b actin RT-PCR product in RNA samples tested
confirmed the integrity and equal loading of RNA. Fur-
thermore, the relative levels of expression of IRF-3 and
transfected IRF-7 and its mutants were also determined.
In infected cells overexpressing IRF-3 or a fusion protein
containing the IRF-3 DBD and AD from the NFkB p65
subunit (Figs. 4B and 4C), the endogenous IFNA genes
were not induced, while cells expressing IRF-7 could
express IFNA genes after viral infection. However, nei-
ther the IRF-7 (1–237) nor IRF-7 (1–349) deletion mutant
induced expression of IFNA genes. It is noteworthy that
these two mutants activated IFNA4 reporter in transient
transfection assay (Au et al., 1998). This result suggests
that the C-terminal region (237–514) of IRF-7 is required
for activating endogenous IFNA genes. As expected,
overexpression of full-length IRF-7 phosphorylation mu-
tants, IRF-7 FL ph- (F483S, A484S) or IRF-7 FL (2A)
(A483S, A484S), did not activate the endogenous IFNA
gene expression in infected 2FTGH cells. Also while
cotransfection of IRF-7 with IRF-7 DN (237–514) com-
pletely abolished induction of IFNA genes, the IRF-7 DN
an intact IRF -7 protein. (A) Conditions for the semiquantitative RT-PCR.
ressing 2FTGH cells: 0.33 mg (lane 1), 1mg (lane 2), or 3.3 mg (lane 3)
m 1 mg of RNA was used for PCR by 25 cycles (lane 4), 30 cycles (lane
of amplification were used for all the RT-PCR performed in Figs. 1, 3B,
osttransfection, cells were infected with Sendai virus for 6 h. The levels
amplify the 39 part of the IRF -3 mRNA cannot detect the expression
er Materials and Methods. Two sets of primers were used to amplify
CTG and 39 primer GTACACCTTGTGCGGGTC) specific for the 59 end
). For the detection of IRF -7 transcript in the other transfected cells, a
erials and Methods. (C) A summary of the result from Fig. 3B. The 1
s detected by the ethidium bromide staining. ND, not done.quires
-7 exp
ved fro
cycles
16 h p
used to
ed und
GCGCC
(1–349ph- had only a small effect. These results indicate that
the S483 and S484 are critical both for IRF-7- and for
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277FUNCTIONAL ASSOCIATION BETWEEN IRF -3 AND IRF -7IRF-7 DN (237–514)-mediated activity and that transcrip-
tional activation of endogenous IFNA, genes unlike tran-
sient transfection (Au et al., 1998), requires full-length
RF-7.
Interestingly, expression of IRF-7 mutants, IRF-7 (1–
37) and IRF-7 (1–349), suppressed the virus-induced
FNB expression. Consistent with this result, the synthe-
is of biological active Type I IFN (IFNB) from these cells
50 U/ml) was about 15 and 12% of virus-infected cells
ransfected with IRF-3 expression plasmid (391 U/ml) and
mpty vector (317 U/ml), respectively. It is likely that this
bservation may result from a competition with binding
f IRF-3 and IRF-7 to IFNB promoter. The inability of IRF-7
N (237–514) to suppress IFNB expression is in contrast
o the observation made in the infected L929 cells that
onstitutively express IRF-7 DN (237–514). We specu-
FIG. 5. Detection of binding of IRF -3 and IRF -7 by GST pull-down ass
and labeled with 35S-methionine. The respective proteins resolved on 10
protein representing 15% of the input was then used for the GST pu
GST/IRF -3 fusion protein is shown in the middle panel. No binding to GS
art of GST/IRF -7 (300–514) is shown in the right panel. (B) Schematic p
RF -7 mutant. The percentage of retention as measured by the phospho
418–473) which interacts with IRF -3 is shown as well as the alignme
onserved leucine (L) and glycine (G) residues that were shown to beated that this difference may be caused by the overex-
ression of IRF-7 in 2FTGH cells but not in L-929 cells.Since IRF-3 and IRF-7 are both targeted by IRF-7 DN
(237–514), it is conceivable that the activity of IRF-7 DN
(237–514) is conversely correlated with the relative level
of IRF-3 and IRF-7.
Determination of the interaction between IRF-7 and
IRF-3
Since IRF-7 DN (237–514) exhibited inhibitory effect on
virus-induced expression of IFNA and IFNB genes, we
hypothesized that the mechanism underlying the IRF-7
DN (237–514) activity may be through disrupting the
interaction between IRF-3 and IRF-7. We, therefore, used
GST pull-down assay to measure the binding of in vitro
labeled IRF-7 and its deletion mutants to the immobilized
GST/IRF-3 fusion protein. As shown in Fig. 5A, while
IRF -7 deletion mutants were translated in the rabbit reticulocyte lysate
–polyacrylamide gel are shown on the left. The amount of each labeled
assay. Binding of in vitro translated IRF -7 proteins to immobilized
e was detected. Binding of in vitro translated IRF -7 FL to the C-terminal
tion of the IRF -7 functional domains and the regions encoded by each
r is given. The amino acid sequence of the C-terminal domain of IRF -7
orresponding region of IRF -3 and IRF -8 (ICSBP). Asterisk marks the
tant for the interaction between IRF -8 and IRF -1 or IRF -2.ay. (A)
% SDS
ll-down
T alon
resenta
rimageneither IRF-7 nor its deletion mutants bind GST alone,
full-length IRF-7 (1–514) and its deletion mutants IRF-7
w
i
i
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278 AU, YEOW, AND PITHA(1–237) and (237–514) bind to full-length IRF-3 with com-
parable affinity as determined by the percentage of re-
tention. Only the IRF-7 mutant (237–418) did not bind
IRF-3. To map the carboxyl terminal region of IRF-7 that
interacts with IRF-3, we analyzed the binding of IRF-7 IAD
(239–473) and IRF-7 RD (418–514) to GST/IRF-3. The re-
sult showed that both of these proteins can bind IRF-3
(Figs. 5A and 5B). These results indicate that IRF-7 is
able to bind to IRF-3 through two regions: one is located
within the N-terminal half (1–237) of the protein and the
other is located between a.a. 418 and 473. Since IRF-7
DN (237–514) is missing in the N-terminal part of IRF-7,
we have not characterized in details this binding site.
Interestingly, we have also found that IRF-7 can dimerize
with itself through the C-terminal region (300–514) (Fig.
5A) and with IRF-7 DN (data not shown). The region of
IRF-7 (237–418) which is incapable of binding to the IRF-3
(Figs. 5A and 5B) did not exhibit a dominant negative
effect on the expression of endogenous IFNA genes (Fig.
4C). To further confirm this finding, the synthesis of bio-
logical active Type I IFN from these cells was deter-
mined. In agreement with the RT-PCR result, the IFN titer
in IRF-7 DN (237–514)-transfected cells (90 U/ml) is sig-
nificantly lower than that in IRF-7 (237–418)-transfected
cells (282 U/ml). These results support the idea that IRF-7
DN (237–514)-mediated effect is derived from a direct
interaction between IRF-7 DN (237–514) and IRF-3 and
IRF-7.
To map the domain of IRF-3 that interacts with IRF-7,
we examined the binding of deletion mutants of IRF-3
expressed as GST fusion proteins (Fig. 6A) to the in vitro
translated full-length IRF-7. IRF-7 did not bind the N-
terminal half (1–231) of IRF-3 and the interaction domain
in IRF-3 was mapped to a.a 306–427; this region overlaps
with the IRF-3 IAD (199–375) (Fig. 6A).
To determine whether the interaction between IRF-3
and IRF-7 DN (237–514) can also occur in vivo, the lysate
from 2FTGH cells transfected with IRF-3 expression plas-
mid and Flag-tagged IRF-7 DN (237–514) or Flag-tagged
IRF-7 DN ph- were immunoprecipitated with anti-Flag
antibody. The immunoprecipitated proteins were re-
solved by SDS–PAGE and the presence of IRF-3 was
determined by Western blot. As shown in Fig. 6B, the
coprecipitation of IRF-7 DN (237–514) with IRF-3 could be
detected only in the infected cells; in contrast, very little
binding of IRF-7 DN ph- to IRF-3 was observed in these
cells. These result suggest that virus-induced phosphor-
ylation may facilitate the interaction between IRF-3 and
IRF-7 DN (237–514) in vivo.
Overexpression of IRF-7 DN (237–514) decreases the
binding of IRF-3 and IRF-7 to IFNA1 VRE in infected
cellsWe have shown previously that both IRF-7 and IRF-3
can bind to the VRE of IFNA1 promoter (Yeow et al.,2000). We have therefore examined whether overexpres-
sion of IRF-7 DN (237–514) in the transfected cells will
affect binding of these two IRFs to this VRE. The binding
was measured using the DNA pull-down assay in which
the oligonucleotides corresponding to the VRE of IFNA1
promoter, immobilized to magnetic beads, were incu-
bated with whole-cell lysates from uninfected and in-
fected 2FTGH cells, overexpressing IRF-7 alone or IRF-7
and IRF-7 DN (237–514). As shown in Fig. 7, IRF-3 from
infected cells but not from uninfected cells binds to
IFNA1 VRE and no binding to the beads only was de-
tected (lane indicated by an arrow). When IRF-7 DN
(237–514) was expressed in these cells, binding of IRF-3
FIG. 6. Mapping the interacting domain by which IRF -3 interacts with
IRF -7. (A) Left: Mobility of the GST IRF -3 fusion proteins, in SDS–PAGE,
which were used for GST pull-down assay. Right: Binding of in vitro
translated full-length IRF -7 to the respective GST/IRF -3 fusion protein.
The schematic presentation of the GST IRF -3 fusion proteins used in
the pull-down assay is shown. The percentage of retention measured
by phosphorimager is given. AI: Auto-inhibition. (B) Coprecipitation of
IRF -3 and IRF -7 DN from infected cells. 2FTGH cells were transfected
with plasmid encoding Flag-tagged IRF -7 DN, Flag-tagged IRF -7 DN
ph-, or vector, pcDNA. Sixteen hours after the transfection, cells were
left uninfected or infected with Sendai virus for 4 h. Two hundred mg of
hole-cell extracts from uninfected or infected cells was used for
mmunoprecipitation with anti-Flag monoclonal antibody (M28). Precip-
tated proteins were resolved on SDS–PAGE and IRF -3 was detected by
estern blot with anti-IRF -3 antibody. The relative level of IRF -3 protein
n cell lysate before immunoprecipitation is shown by Western blot.to the IFNA1 VRE was significantly reduced. The reduc-
tion of IRF-3 binding was not a result of lower levels of
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279FUNCTIONAL ASSOCIATION BETWEEN IRF -3 AND IRF -7IRF-3 protein in these cells, since the levels of IRF-3
determined by Western blot were comparable in all cell
lysates examined. Since the efficiency of transfection of
IRF-7 DN (237–514) in 2FTGH cells in these experiments
is about 70%, the residual IRF-3 binding activity (compare
lane 2 and 4) may be derived from the IRF-3 in untrans-
fected cells. Similarly, binding of IRF-7 was also de-
creased in the presence of IRF-7 DN (237–514). However,
it is noticeable that IRF-7 can bind to the IFNA1 VRE at
low levels even in the absence of virus infection. The
ability of IRF-7 DN (237–514) to decrease the binding of
IRF-3 and IRF-7 to IFNA1 VRE suggests that the DNA-
binding affinity IRF-3/IRF-7 DN dimer which contains only
one DNA-binding domain is not sufficient for stable bind-
ing to IFNA1 VRE. Taken together, the reduction of bind-
ing of IRF-3 and IRF-7 correlates with the observed sup-
pression of endogenous IFNA gene expression by IRF-7
DN (237–514), thus suggesting that IRF-7 DN targets both
IRF-7 and IRF-3 functions.
DISCUSSION
It was shown that IRF-7 is required for the expression
of IFNA genes in infected human and mouse cells (Yeow
et al., 2000). To better understand the molecular interac-
tion between IRF-7 and the other components of the
IFNA-specific transcription complex, we have studied the
mechanism by which IRF-7 DN (237–514) inhibited the
virus-induced expression of endogenous IFNA and IFNB
genes. Since IRF-7 DN (237–514) does not contain DBD,
the inhibitory effect is likely a result of an interference of
FIG. 7. Expression of IRF -7 DN (237–514) suppresses binding of
RF -3 and IRF -7 to the IFNA1 VRE. 2FTGH cells were transfected either
ith IRF -7 expression plasmid alone or together with the IRF -7 DN.
ixteen hours after transfection, the transfected cells were infected
ith Sendai virus for 3 h or left uninfected. The whole-cell extracts were
ncubated with magnetic beads to which IFNA1 VRE was bound. After
entle washing, the bound proteins were analyzed on SDS–PAGE and
RF -3 and IRF -7 were detected by Western blot. The level of IRF -3 and
RF -7 present in the whole-cell extracts were analyzed by Western blot.
he arrow marks binding of extracts from infected, IRF -7 expressing
ells to magnetic bead alone.the protein–protein interactions that are essential for the
virus-induced IFNA gene expression. It was shown pre-viously that both IRF-3 and IRF-7 participate in Sendai
virus-mediated induction of IFNB gene (Whateleff et al.,
1998); however, IFNB gene can be induced in the ab-
sence of IRF-7 (Yeow et al., 2000). The ability of IRF-7 DN
(237–514) to inhibit expression of IFNB gene in the ab-
sence of IRF-7 indicates that IRF-7 DN (237–514) targets
not only IRF-7 but also IRF-3.
We have shown that IRF-7 DN (237–514) is efficiently
phosphorylated upon virus infection and that S483 and
S484 of IRF-7 are critical both for the IRF-7-mediated
activation of endogenous IFNA genes and for the IRF-7
DN (237–514)-mediated inhibitory effect. Since no phos-
phorylation was detected in IRF-7 DN in which S483A
and S484F were changed to an alanine or phenylalanine,
this result suggested that the other serine and threonine
residues of IRF-7 DN (237–514) were not the targets for
virus-induced phosphorylation or that phosphorylation of
S483 and S484 is a prerequisite for further phosphoryla-
tion of IRF-7. It was shown that in IRF-3, S385 and S386
regulated the phosphorylation of a downstream serine/
threonine cluster (Lin et al., 1999). Maniatis and co-
workers have shown that IRF-7A and IRF-7B are consti-
tutively phosphorylated in HEC-1B cells and only a mar-
ginal increase in phosphorylation was detected upon
virus infection (Wathelet et al., 1998). In contrast, we
observed a significant increase of phosphorylation of
IRF-7 DN (237–514) in infected 2 FTGH cells. Most likely,
this discrepancy reflects different constitutive levels of
activated kinase in these two cell types.
Focusing on the characterization of IRF-7 functional
domains required for the expression of endogenous
IFNA genes in human 2FTGH cells, we have found that
only full-length IRF-7 can activate IFNA gene expression
in the infected cells. Overexpression of the IRF-3/p65
fusion protein or IRF-7 C-terminal truncation mutants
(1–237 and 1–349) which activated IFNA4 promoter in a
transient reporter assay (Au et al., 1998; Schafer et al.,
1998) did not support transcriptional activation of the
endogenous IFNA genes.
Several IRF family members were shown to interact
with each other through the IAD and as a result, their
DNA-binding activity can be modulated (Sharf et al.,
1997). By using the GST pull-down assay, we have shown
that IRF-3 and IRF-7 can directly interact with each other.
The IRF-7 (237–418) which does not bind IRF-3 in vitro
failed to modulate the virus-mediated induction of IFNA
genes. The observation of interaction between the N-
terminal half of IRF-7 (1–237) and IRF-3 was unexpected.
Interestingly, this region contains a potential PEST do-
main (RGGGPPPEAETAER) which has a score (18.07)
higher than that of PU.1 (PESTfind). The interaction be-
tween PEST domain of PU.1 and IAD of IRF-4 and IRF-8
was previously demonstrated (Meraro et al., 1999). This
PEST domain is unique to IRF-7 and is absent in all the
other IRFs. Furthermore, it has been suggested recently
that it may contribute a low stability to IRF-7 protein (Sato
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of IRF-7 and IRF-3 occurs through IAD-like domains and
it is greatly enhanced by virus-induced phosphorylation.
It was shown that mutations of L 331P and G377D in IAD
of IRF-8 prevented the complex formation between IRF-8
and IRF-1 or IRF-2, as well as its binding to PRDI (Meraro
et al., 1999). Interestingly, these two amino acids are
conserved both in the interacting domains of IRF-7 (418–
473) and IRF-3 (306–427) and are deleted in IRF-7 (237–
418), an IRF-7 deletion mutant that can neither bind IRF-3
or inhibit IRF-7-mediated induction of IFNA genes.
Altogether these data indicate IRF-3 and IRF-7 het-
erodimers are effective transcription activators of IFNA
genes in infected cells and that IRF-7 DN (237–514)
targets both IRF-3 and IRF-7. The affinity of IRF-7 DN
(237–514) for IRF-3 is significantly enhanced by virus-
induced phosphorylation of IRF-7DN on S483 and S484.
While both IRF-3 and IRF-7 were shown to bind DNA as
homodimers, our data indicate that binding of IRF-7DN to
IRF-7 or IRF-3 significantly decreases the DNA binding
capacity of IRF-3 and IRF-7. This may be, however, only
one of the mechanisms by which IRF-DN inhibits the
induction of Type I IFN genes in infected cells, since the
interaction of IRF-3 and IRF-7 with transcription coacti-
vators CBP/p300 is likely to be altered as well in the
presence of IRF-7 DN (237–514). This possibility has
been examined.
MATERIALS AND METHODS
Cells, virus, and transfection. 2FTGH cells, L-929 and
293 cells were grown in Dulbecco’s modified Eagle’s
medium supplemented with 10% fetal bovine serum.
L-929 cells constitutively expressing IRF-7 DN (237–514)
were established by transfecting L-929 cells with IRF-7
DN (237–514) expressing plasmid, followed by over 2
weeks of G418 selection. The resistant clones were
pooled and used in the study. All the transfections were
done using Superfect transfection reagent (Qiagen Inc).
Routinely, 5 mg of DNA was used to transfect 2 3 106
cells. For infection, Sendai virus purchased from Specific
Pathogen Free Avian Supply (Preston, CT) at 240 hem-
agglutinin (HA) units/60 mm plate were used for infecting
2FTGH cells and 293 cells (Yeow et al., 2000), whereas
New Castle Disease Virus (NDV; LaSota Strain, NJ) at 46
HA units/60 mm plate was used for infecting L-929 cells.
Plasmids. All the IRF-7 expression plasmids express-
ing various regions of IRF-7 (a.a. 1–237, 237–514, 237–
418, and 418–514) and IRF association domain (a.a. 293–
479) were constructed by cloning the PCR-amplified frag-
ments into pCMV-Tag 2 or 4 vector (Stratagene Inc.). The
GST IRF-3 expression plasmids were constructed by
cloning PCR-amplified IRF-3 fragment to pGEX4T-2 vec-
tor. GST/IRF-7, IRF-3/p65, GFP/IRF-7, and GFP/IRF-3 plas-
mids were described previously (Au et al., 1998; Lin et al.,
998; Schafer et al., 1998). IRF-7 and IRF-7 DN (237–514)
t
wphosphorylation mutants [IRF-7 FL ph-, IRF-7 FL (2A) and
IRF-7 DN ph-] were constructed by using the Quick
Change mutagenesis system (Stratagene Inc.). All the
plasmids used in this study were sequenced and the
proteins encoded by these plasmids were detected in
the transfected cells.
GST pull-down assay. GST fusion protein was obtained
from IPTG induced (1 mM, 3 h) BL21 bacteria that had
been transformed with the indicated pGEX IRF-7 or pGEX
IRF-3 expression plasmids. Bacterial lysates were incu-
bated with glutathione sepharose beads followed by
extensive wash with PBS containing 1% of Triton X-100.
Coomassie blue staining of GST fusion proteins resolved
by SDS–PAGE was used to quantify the amount of pro-
tein on the beads. Equal amounts of GST fusion proteins
and beads were then applied in each pull-down assay.
The binding proteins were translated in vitro in rabbit
eticulocyte lysate (Promega Inc.) and labeled with 35S-
methionine. The amount of these proteins was quantified
by phosphorimager. GST fusion protein immobilized on
the beads and the labeled proteins were incubated in
300 ml of incubation buffer (10 mM Tris–Cl, pH 7.6, 75 mM
KCl, 0.1 mM EDTA, 2.5 mM MgCl2, 1 mM DTT, 0.1% NP-40,
500 mg BSA/ml, and 8% glycerol) at 4°C for 2 h. The
beads were then washed 3 times at room temperature
and the bound proteins were eluted and resolved by
SDS–PAGE. The percentage of retention was measured
by phosphorimager.
Reverse transcription–PCR analysis. Total RNA was
purified from cells by guanidine isothiocynate method.
Isolated RNA was first treated with DNase I and then
heat-inactivated. Routinely, 1 mg of RNA sample was
everse-transcribed into cDNA using oligo-dT (12–18) as
rimer in 30 ml final volume and 2 ml of the RT reaction
ixture was used for PCR. Primer sets that amplify mu-
ine (Mu)b-actin (36), MuIFNA and MuIFNB (35), human
Hu)b-actin, HuIFNA, and HuIRF-7 (30, 34) were previ-
usly described. The following primer sets are used for
mplifying HuIFNB (59 primer, TTGTGCTTCTCCACTA-
AGC and 39 primer, CTGTAAGTCTGTTAATGAAG) and
uIRF-3 (59 primer, CTGAAGCGGCTGTTGGTG and 39
rimer ACCATGAGGAGCGAGGGC). The amount of
DNA used and the number of cycles of amplification
ere determined to be within the linear range of ampli-
ication.
Metabolic labeling of cellular proteins with 32Pi. 293
cells were transfected with 5 mg of plasmid encoding
either IRF-7 DN (237–514) or its corresponding phosphor-
ylation mutant (IRF-7 DN ph-). Sixteen hours posttrans-
fection, medium was changed to a phosphate-free
DMEM supplemented with 2% dialyzed serum for 2 h.
Cells were then infected with Sendai virus and labeled
with 0.5 m Ci/ml of 32Pi (Amersham Inc.) for 4 h. The
whole-cell extract (300 mg) was used for immunoprecipi-
ation with anti-Flag antibody and precipitated proteins
ere resolved on 10% SDS–PAGE.
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281FUNCTIONAL ASSOCIATION BETWEEN IRF -3 AND IRF -7DNA-pull-down assay. Double-stranded (ds) oligomers
corresponding to the IFNA1 VRE region (2110 to 253 bp)
were synthesized with biotin at the 59 end of the anti-
ense strand; the ds oligomers were incubated with
treptavidin magnetic beads (Dynal Inc.) for 1 h in TEN
uffer (20 mM Tris pH 8, 1 mM EDTA, 0.1 M NaCl). After
ncubation, the unbound DNA was removed by extensive
ashing with TEN buffer. Nuclear and cytoplasmic ex-
racts pooled and dialyzed against the binding buffer
10% glycerol, 12 mM Hepes, pH 7.9, 5 mM MgCl2, 60 mM
KCl, 0.1 mM DTT, and 0.1 mM PMSF) were then incubated
with the DNA bound magnetic beads for 4 h at 4°C. After
gentle washing, the bound proteins were resolved by
SDS–PAGE and proteins were identified by the Western
blot with the indicated antibody.
IFN assay. The cytopathic assay was used to deter-
mine the level of Type I IFN in the medium as described
previously (Cheung et al., 1991). VSV (moi. 5) was used
as challenging virus and human foreskin fibroblasts as
indicator cells. The IFN tilter in the medium was calcu-
lated based on the antiviral activity relative to that con-
ferred by the IFN standard.
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